Evaluating the Effectiveness of Mitigation Policies for Flattening the COVID-19 Epidemic Curve: Evidence From Five Mexican Cities
Abstract
This paper estimates the benefits of flattening the COVID-19 epidemic curve in the five Mexican cities that concentrate most of the cases in the country. On average, the analysis finds that mitigation policies reduced the number of total cases in 46%. A smaller epidemic allows each city’s the healthcare system to better manage cases by delaying the pressure on health resources. The result is that 69 % of the deaths that would have occurred were averted by mitigation policies (about 129,000 people). These benefits can be monetized as about 219 billion USD, which represents 8.4% of the Mexican GDP in 2019.
Downloads
References
Capistrán,M., Capell, A. y Christen, A. (2020). Modelo AMA. Informe 28 de mayo de 2020. Ecosistema Nacional Informático COVID-19. https://coronavirus.conacyt.mx/proyectos/ama.html. Consultado el 31 de mayo de 2020.
CONAPO (2020). Proyecciones de la Población de los Municipios de México, 2015-2030. https://www.gob.mx/conapo/documentos/proyecciones-de-la-poblacion-de-los-municipios-de-mexico-2015-2030. Consultado el 31 de mayo de 2020.
Ferguson, N. et al. (2020). Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team.
Gaythorpe, K. et al. (2020) Report 8: Symptom progression of COVID-19. Imperial College COVID-19 Response Team.
Graff, M., et al. (2020), Medición de Movilidad usando Facebook, Google y Twitter. Ecosistema Nacional Informático COVID-19. https://coronavirus.conacyt.mx/proyectos/movilidad.html. Consultado el 30 de mayo de 2020.
Greenstone, M., y Nigam, V. (2020). Does Social Distancing Matter?. University of Chicago, Becker Friedman Institute for Economics Working Paper.
Kucharski, A. et al. (2020). Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The Lancet Infectious Diseases.
Li, Q. et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine.
OECD. (2012). Mortality Risk Valuation in Environmental, Health and Transport Policies. OECD Publishing.
OECD. (2019). Hospital beds and discharge rates. https://www.oecd-ilibrary.org/sites/0d67e02a-en/index.html?itemId=/content/component/0d67e02a-en. Consultado el 30 de mayo de 2020.
Moghadas, S. M. et al. (2020). Projecting hospital utilization during the COVID-19 outbreaks in the United States. Proceedings of the National Academy of Sciences, 117(16), 9122-9126.
Nishiura, H., Linton, N. M., y Akhmetzhanov, A. R. (2020). Serial interval of novel coronavirus (COVID-19) infections. International Journal of Infectious Diseases.
Robinson, L. A., Hammitt, J. K., y O’Keeffe, L. (2019). Valuing mortality risk reductions in global benefit-cost analysis. Journal of Benefit-Cost Analysis, 10(S1), 15-50.
Rojas, I. (2020). On the Economic Benefits and Costs of COVID-19 Mitigation Measures in Mexico. Documento de trabajo, SSRN 3592209.
Secretaria de Salud. (2020), Catálogo de Clave Única de Establecimientos de Salud-CLUES, http://www.dgis.salud.gob.mx/contenidos/sinais/s_clues.html. Consultado el 30 de mayo de 2020.
Wu, Z., y McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 323(13), 1239-1242.
